logo
EBITDA vs Operating profit vs Net profit: Understanding key profitability metrics with Indian company examples

EBITDA vs Operating profit vs Net profit: Understanding key profitability metrics with Indian company examples

Business Upturn13 hours ago

By Aditya Bhagchandani Published on June 30, 2025, 21:35 IST
When analyzing company results in India, you'll often hear terms like EBITDA, Operating Profit, and Net Profit. While all three relate to profitability, each tells a different story about how a company is performing financially.
Let's simplify these concepts using real-life examples from the Indian stock market. What is EBITDA?
EBITDA stands for: Earnings Before Interest, Taxes, Depreciation, and Amortization.
It reflects the core operating performance of a company before factoring in financing costs, government taxes, and accounting adjustments like depreciation.
Formula:
EBITDA = Revenue – Operating Expenses (excluding Depreciation and Amortization)
Example:
For a manufacturing company like Tata Motors, EBITDA helps investors focus on operating efficiency without worrying about debt costs or tax impacts. What is Operating Profit (EBIT)?
Operating Profit, also called EBIT (Earnings Before Interest and Taxes), is calculated after deducting depreciation and amortization from EBITDA.
It reflects how much profit the business generates from its core operations before interest and taxes.
Formula:
Operating Profit = EBITDA – Depreciation – Amortization
Example:
If Maruti Suzuki reports EBITDA of Rs 5,000 crore and has depreciation of Rs 500 crore,
then Operating Profit (EBIT) = Rs 4,500 crore. What is Net Profit?
Net Profit (also called Net Income or Profit After Tax) is the final profit figure after subtracting interest expenses, taxes, and other non-operating costs from Operating Profit.
Formula:
Net Profit = Operating Profit – Interest – Taxes – Other expenses + Non-operating income
Example:
If Infosys reports an Operating Profit of Rs 4,500 crore, pays Rs 200 crore interest, and Rs 1,000 crore in taxes,
then Net Profit = Rs 4,500 crore – Rs 200 crore – Rs 1,000 crore = Rs 3,300 crore Quick comparison: Metric Includes Excludes EBITDA Operating income (excluding depreciation) Interest, taxes, depreciation, amortization Operating Profit Operating income (after depreciation) Interest, taxes Net Profit Final profit after all costs None Why understanding the difference matters: EBITDA shows core operational performance.
Operating Profit reflects how efficiently the business handles operating costs including depreciation.
Net Profit shows how much money is actually left for shareholders after all expenses.
For example, heavily indebted companies like Vodafone Idea may have a good EBITDA but poor Net Profit due to high interest costs. Conclusion:
When reviewing quarterly results or choosing stocks to invest in, it's crucial to check all three: EBITDA, Operating Profit, and Net Profit.
Each tells a different part of the company's profitability story.
Ahmedabad Plane Crash
Aditya Bhagchandani serves as the Senior Editor and Writer at Business Upturn, where he leads coverage across the Business, Finance, Corporate, and Stock Market segments. With a keen eye for detail and a commitment to journalistic integrity, he not only contributes insightful articles but also oversees editorial direction for the reporting team.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Bajaj Auto June 2025 Sales: Company reports marginal 1% YoY growth to 3.6 lakh units
Bajaj Auto June 2025 Sales: Company reports marginal 1% YoY growth to 3.6 lakh units

Business Upturn

time2 hours ago

  • Business Upturn

Bajaj Auto June 2025 Sales: Company reports marginal 1% YoY growth to 3.6 lakh units

Bajaj Auto Limited posted a marginal 1% year-on-year (YoY) increase in total sales for June 2025, driven by strong export performance in both two-wheelers and commercial vehicles, even as domestic demand showed signs of weakness. June 2025 Sales Snapshot In June 2025, Bajaj Auto recorded total sales of 3,60,806 units, compared to 3,58,477 units in June 2024. While total two-wheeler sales declined slightly by 2% YoY to 2,98,484 units, strong momentum in the commercial vehicle (CV) segment — up 14% YoY to 62,322 units — helped offset the dip. Two-Wheelers Domestic : 1,49,317 units (down 16%) Exports : 1,49,167 units (up 18%) Commercial Vehicles Domestic : 39,143 units (up 69%) Exports : 23,179 units (up 49%) Overall domestic sales for the month came in at 1,88,460 units, marking a 13% YoY decline. However, exports surged 21% to 1,72,346 units, highlighting the company's growing international footprint. Q1 FY26 (April–June 2025) Performance For the April–June 2025 quarter, Bajaj Auto registered total sales of 11,11,237 units, a slight increase from 11,02,056 units in the same period last year. Two-Wheelers : Domestic : 5,29,344 units (down 9%) Exports : 4,19,447 units (up 14%) Commercial Vehicles : Domestic : 1,05,464 units (down 2%) Exports : 56,982 units (up 32%) Combined exports grew 16% YoY during the quarter, while domestic sales fell 8%, reflecting softer demand trends in the Indian market. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Apollo Hospitals shares surge 4% after board approves plan to list pharmacy, digital health arms
Apollo Hospitals shares surge 4% after board approves plan to list pharmacy, digital health arms

Business Upturn

time2 hours ago

  • Business Upturn

Apollo Hospitals shares surge 4% after board approves plan to list pharmacy, digital health arms

Shares of Apollo Hospitals climbed 4% after the company announced a strategic restructuring to unlock value by spinning off its pharmacy and digital health businesses into a separate listed entity. As of 9:37 AM, the shares were trading 4.10% higher at Rs 7,539.00. The board of Apollo Hospitals and its subsidiary, Apollo HealthCo, has given in-principle approval for a composite scheme of arrangement. As per the proposal, Apollo will demerge its omni-channel pharmacy, telehealth services, and digital health business into a newly formed entity, tentatively referred to as NewCo. Following the demerger, Apollo HealthCo will be merged into NewCo. In addition, Keimed Pvt Ltd — a major pharmaceutical distributor in India — will also be brought under NewCo, creating a fully integrated pharmacy and digital healthcare platform. The company aims for the new unit to achieve ₹25,000 crore in revenue by FY27. NewCo will also acquire the remaining 74.5% stake in Apollo Medicals Pvt Ltd, which holds full ownership of Apollo Pharmacies Ltd. This move consolidates control over the retail pharmacy business. Apollo Hospitals will retain a 15% stake in the new entity. The listing of NewCo on Indian exchanges is expected within 18–21 months, subject to regulatory approvals. The restructuring is aimed at streamlining operations and boosting long-term shareholder value. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

Dixon Technologies shares slip 3% after Morgan Stanley downgrade stock to ‘Underweight'
Dixon Technologies shares slip 3% after Morgan Stanley downgrade stock to ‘Underweight'

Business Upturn

time2 hours ago

  • Business Upturn

Dixon Technologies shares slip 3% after Morgan Stanley downgrade stock to ‘Underweight'

By Aman Shukla Published on July 1, 2025, 09:52 IST Shares of Dixon Technologies fell 3% in early trade after global brokerage Morgan Stanley downgraded the stock to 'Underweight' and lowered its target price to ₹11,563. As of 9:51 AM, the shares were trading 2.96% lower at Rs 14,539.00. In its note, the brokerage cited concerns over increased competition in Dixon's core Electronics Manufacturing Services (EMS) segment, particularly after the Production Linked Incentive (PLI) benefits phase out. It also pointed to a likely slowdown in the company's earnings growth over the medium term. Morgan Stanley estimates that Dixon's core EMS business could see earnings growth drop by 46% during FY25–27, followed by a more moderate 18% growth rate between FY27–30. The firm believes that this slowdown could weigh on the stock's performance going forward. While the company's move into component manufacturing is seen as a positive strategic step, Morgan Stanley flagged execution challenges, noting that success in this segment hinges on securing technology partnerships, regulatory approvals, and maintaining cost efficiency. On Dixon's entry into the display fabrication space, the brokerage highlighted the deep cyclical nature of the business. It noted that such a venture would require sustained capital investment and R&D expenditure, adding another layer of complexity to the company's growth plans. Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions. Author or Business Upturn is not liable for any losses arising from the use of this information. Ahmedabad Plane Crash Aman Shukla is a post-graduate in mass communication . A media enthusiast who has a strong hold on communication ,content writing and copy writing. Aman is currently working as journalist at

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store